| Q64955305 | A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. |
| Q36959330 | A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells |
| Q38196154 | A new angle on blood-CNS interfaces: a role for connexins? |
| Q47132581 | A noradrenergic lesion aggravates the effects of systemic inflammation on the hippocampus of aged rats |
| Q37798553 | A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers |
| Q38794750 | A three-dimensional model of the human blood-brain barrier to analyse the transport of nanoparticles and astrocyte/endothelial interactions. |
| Q94464038 | Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation |
| Q38959066 | Activation of VEGF/Flk-1-ERK Pathway Induced Blood-Brain Barrier Injury After Microwave Exposure |
| Q46634157 | Acute hypertension induces oxidative stress in brain tissues |
| Q38097385 | Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities |
| Q48504235 | Adrenomedullin improves the blood-brain barrier function through the expression of claudin-5. |
| Q38095485 | Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles |
| Q34000631 | Advances in strategies to improve drug delivery to brain tumors |
| Q38980388 | African trypanosomes and brain infection - the unsolved question |
| Q50582458 | Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes. |
| Q37155864 | Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure |
| Q38469837 | An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity. |
| Q30813675 | Analgesic efficacy and safety of DALDA peptide analog delivery to the brain using oil-in-water nanoemulsion formulation |
| Q46762520 | ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9. |
| Q38056688 | Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis |
| Q93049131 | Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis |
| Q26745578 | Aquaporins and Brain Tumors |
| Q30990964 | Assessing Treatment Response Through Generalized Pharmacokinetic Modeling of DCE-MRI Data |
| Q43488684 | Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis |
| Q28131675 | Astrocyte-endothelial interactions at the blood-brain barrier |
| Q28282324 | Astrocytes in multiple sclerosis: a product of their environment |
| Q38844684 | Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. |
| Q38888246 | Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins |
| Q48232754 | Basic fibroblast growth factor modulates density of blood vessels and preserves tight junctions in organotypic cortical cultures of mice: a new in vitro model of the blood-brain barrier. |
| Q59793802 | Benchmarking in vitro tissue-engineered blood-brain barrier models |
| Q37223061 | Beta8 integrin regulates neurogenesis and neurovascular homeostasis in the adult brain |
| Q42507589 | Bidirectional apical-basal traffic of the cation-independent mannose-6-phosphate receptor in brain endothelial cells. |
| Q38849743 | Biocompatibility and nanostructured materials: applications in nanomedicine |
| Q28973613 | Biological and medical applications of a brain-on-a-chip |
| Q37010459 | Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds |
| Q87870397 | Blood brain barrier (BBB)-disruption in intracortical silicon microelectrode implants |
| Q28067855 | Blood brain barrier: An overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking |
| Q35209976 | Blood vessels and nerves: common signals, pathways and diseases |
| Q53513684 | Blood-Brain Barrier Disruption and Perivascular Beta-Amyloid Accumulation in the Brain of Aged Rats with Spontaneous Hypertension: Evaluation with Dynamic Contrast-Enhanced Magnetic Resonance Imaging. |
| Q48108361 | Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A2A and A2B. |
| Q48366273 | Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis |
| Q36558683 | Blood-brain barrier and chemotherapeutic treatment of brain tumors |
| Q34611476 | Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions |
| Q34056846 | Blood-brain barrier breakdown and repair by Src after thrombin-induced injury |
| Q40515003 | Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia |
| Q47168123 | Blood-brain barrier breakdown promotes macrophage infiltration and cognitive impairment in leptin receptor-deficient mice |
| Q89669447 | Blood-brain barrier development: Systems modeling and predictive toxicology |
| Q47910464 | Blood-brain barrier dysfunction and recovery after ischemic stroke |
| Q38058374 | Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis |
| Q61443992 | Blood-brain barrier permeability and physical exercise |
| Q52141712 | Blood-brain barrier properties in vitro depend on composition and assembly of endogenous extracellular matrices. |
| Q42002170 | Blood-brain barrier regulation: Environmental cues controlling the onset of barrier properties |
| Q46303600 | Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface |
| Q40377619 | Blood-brain barrier-specific properties of a human adult brain endothelial cell line |
| Q37015412 | Blood-brain barrier: structural components and function under physiologic and pathologic conditions |
| Q58090261 | Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics |
| Q33786343 | Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. |
| Q35853941 | Bone marrow mesenchymal stem cells ameliorate neurological deficits and blood-brain barrier dysfunction after intracerebral hemorrhage in spontaneously hypertensive rats |
| Q48616947 | Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins |
| Q37072186 | Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging |
| Q38066590 | Brain metastases from prostate cancer: an emerging clinical problem with implications for the future therapeutic scenario. |
| Q39035128 | Brain metastasis: Unique challenges and open opportunities |
| Q37417409 | Breaching the blood-brain barrier as a gate to psychiatric disorder |
| Q48265505 | Building up the blood-brain barrier |
| Q38769532 | CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. |
| Q34905120 | Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases |
| Q37074777 | Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells |
| Q39955713 | Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling |
| Q26827093 | Cell-culture models of the blood-brain barrier |
| Q37621370 | Cellular elements of the blood-brain barrier |
| Q31079099 | Central nervous system regulation of eating: Insights from human brain imaging |
| Q47710646 | Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy. |
| Q57494696 | Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies |
| Q88216177 | Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies |
| Q39378837 | Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). |
| Q50629635 | Characterization of human fetal brain endothelial cells reveals barrier properties suitable for in vitro modeling of the BBB with syngenic co-cultures. |
| Q94585924 | Choroid plexus and the blood-cerebrospinal fluid barrier in disease |
| Q90100833 | Chronic mild hypoxia increases expression of laminins 111 and 411 and the laminin receptor α6β1 integrin at the blood-brain barrier |
| Q47233530 | Chronic mild hypoxia promotes profound vascular remodeling in spinal cord blood vessels, preferentially in white matter, via an α5β1 integrin-mediated mechanism |
| Q39250251 | Clarifying the Ghrelin System's Ability to Regulate Feeding Behaviours Despite Enigmatic Spatial Separation of the GHSR and Its Endogenous Ligand |
| Q28588370 | Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis |
| Q60907416 | Claudin-3-deficient C57BL/6J mice display intact brain barriers |
| Q48091576 | Claudin-5 regulates blood-brain barrier permeability by modifying brain microvascular endothelial cell proliferation, migration, and adhesion to prevent lung cancer metastasis |
| Q61806939 | Claudin-5: gatekeeper of neurological function |
| Q35988085 | Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice |
| Q36938473 | Concepts and mechanisms: crossing host barriers |
| Q60923543 | Condition-specific gene co-expression network mining identifies key pathways and regulators in the brain tissue of Alzheimer's disease patients |
| Q30499651 | Connexin47, connexin29 and connexin32 co-expression in oligodendrocytes and Cx47 association with zonula occludens-1 (ZO-1) in mouse brain |
| Q38511670 | Control of the blood-brain barrier function in cancer cell metastasis |
| Q37942476 | Corticosteroid-use in primary and secondary brain tumour patients: a review |
| Q33841456 | Cross-talk between tight and anchoring junctions-lesson from the testis |
| Q40617060 | Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins |
| Q40167936 | Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles. |
| Q24610752 | Defense at the border: the blood-brain barrier versus bacterial foreigners |
| Q38001793 | Designing prodrugs for the treatment of Parkinson's disease. |
| Q47860080 | Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics. |
| Q48126664 | Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood-brain barrier coculture model |
| Q92308513 | Development of the brain vasculature and the blood-brain barrier in zebrafish |
| Q64102371 | Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies |
| Q37731946 | Diet and age interactions with regards to cholesterol regulation and brain pathogenesis |
| Q48615336 | Different segments of the cerebral vasculature reveal specific endothelial specifications, while tight junction proteins appear equally distributed |
| Q45182499 | Differential P1-purinergic modulation of human Schlemm's canal inner-wall cells. |
| Q31029942 | Dye coupling without gap junctions suggests excitatory connections of gamma-aminobutyric acidergic neurons |
| Q33987878 | Dynamics of CNS barriers: evolution, differentiation, and modulation |
| Q92482674 | Dysregulated claudin-5 cycling in the inner retina causes retinal pigment epithelial cell atrophy |
| Q33663562 | Edema is not a reliable diagnostic sign to exclude small brain metastases. |
| Q33560110 | Effect of amplitude and duration of impulsive pressure on endothelial permeability in in vitro fluid percussion trauma |
| Q43042907 | Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells |
| Q48101075 | Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood–tumor barrier |
| Q48365906 | Effects of erythropoietin on blood-brain barrier tight junctions in ischemia-reperfusion rats |
| Q31153090 | Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression. |
| Q55461261 | Efficacy of Cisplatin-loaded polybutyl cyanoacrylate nanoparticles on the glioblastoma. |
| Q35107926 | Elucidating the principles of the molecular organization of heteropolymeric tight junction strands. |
| Q45965497 | Elucidation of Exosome Migration across the Blood-Brain Barrier Model In Vitro. |
| Q24324232 | Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins |
| Q39365296 | Endothelial cell-cell adhesion and signaling |
| Q35741007 | Endothelial cell-cell junctions: happy together |
| Q37643585 | Endothelial cell-oligodendrocyte interactions in small vessel disease and aging |
| Q37179490 | Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). |
| Q34661088 | Endothelial junction regulation: a prerequisite for leukocytes crossing the vessel wall. |
| Q45188146 | Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression |
| Q34701454 | Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles |
| Q38562421 | Epithelial barrier and oral bacterial infection |
| Q36959343 | Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance |
| Q39910823 | Evaluation of the selected barrier properties of retinal pigment epithelial cell line ARPE-19 for an in-vitro blood-brain barrier model |
| Q37368295 | Evidence for differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature |
| Q36262480 | Excess salt exacerbates blood-brain barrier disruption via a p38/MAPK/SGK1-dependent pathway in permanent cerebral ischemia |
| Q89909722 | Exosome-based small RNA delivery: Progress and prospects |
| Q64108486 | Exosomes Derived From Pericytes Improve Microcirculation and Protect Blood-Spinal Cord Barrier After Spinal Cord Injury in Mice |
| Q37392913 | Exploiting macrophages as targeted carrier to guide nanoparticles into glioma |
| Q37215871 | Exploring tight junction alteration using double fluorescent probe combination of lanthanide complex with gold nanoclusters |
| Q34269018 | Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells |
| Q48204624 | Expression of tight junction proteins by umbilical vein epithelial cells co-cultured with allogenic astrocytes. |
| Q36351793 | Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke |
| Q36052713 | Extracellular proteolytic pathophysiology in the neurovascular unit after stroke |
| Q47286331 | Fatty acid binding protein 5 mediates the uptake of fatty acids, but not drugs, into human brain endothelial cells |
| Q48707747 | Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling |
| Q36404218 | Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model |
| Q91638523 | Fish oil protects the blood-brain barrier integrity in a mouse model of Alzheimer's disease |
| Q34577621 | Fluids and barriers of the CNS: a historical viewpoint |
| Q30477576 | Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats |
| Q36638592 | Frog Virus 3 dissemination in the brain of tadpoles, but not in adult Xenopus, involves blood brain barrier dysfunction |
| Q55455023 | Function of Connexins in the Interaction between Glial and Vascular Cells in the Central Nervous System and Related Neurological Diseases. |
| Q28534449 | Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish |
| Q37080750 | Functional effectiveness of the blood-brain barrier to small water-soluble molecules in developing and adult opossum (Monodelphis domestica) |
| Q36633623 | Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm). |
| Q41382687 | Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction |
| Q52606336 | Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit. |
| Q33660218 | Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse |
| Q38152380 | Glial influence on the blood brain barrier. |
| Q50076163 | Glioblastoma Stem Cells and Their Microenvironment |
| Q40064513 | Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro |
| Q26853743 | Glucocorticoids and endothelial cell barrier function |
| Q35067385 | Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro |
| Q46403676 | Glycosylation of dentin matrix protein 1 is a novel key element for astrocyte maturation and BBB integrity |
| Q39396702 | Guanine nucleotide-binding protein Gαi2: a new partner of claudin-5 that regulates tight junction integrity in human brain endothelial cells |
| Q36914297 | Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease. |
| Q33965984 | Holey barrier: claudins and the regulation of brain endothelial permeability |
| Q26995364 | How do immune cells support and shape the brain in health, disease, and aging? |
| Q93136005 | Human ES-derived MSCs correct TNF-α-mediated alterations in a blood-brain barrier model |
| Q36707822 | Hyperbaric oxygen preconditioning ameliorates blood-brain barrier damage induced by hypoxia through modulation of tight junction proteins in an in vitro model |
| Q39038770 | Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism |
| Q93003140 | Hypoxia-induced disruption of neural vascular barrier is mediated by the intracellular induction of Fe(II) ion |
| Q58768157 | Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels |
| Q38272285 | Immune responses to non-tumor antigens in the central nervous system. |
| Q48427172 | Immunolocalization of tight junction proteins in blood vessels in human germinal matrix and cortex |
| Q47280497 | Immunolocalization of tight junction proteins in the adult and developing human brain |
| Q54629759 | Immunological Response in Early Brain Injury After SAH |
| Q37701119 | Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line |
| Q35782792 | In vitro blood-brain barrier models: current and perspective technologies |
| Q34476565 | In vitro cerebrovascular modeling in the 21st century: current and prospective technologies |
| Q34185789 | In vitro study of the effects of Angiostrongylus cantonensis larvae extracts on apoptosis and dysfunction in the blood-brain barrier (BBB). |
| Q42861335 | Increased expression of the beta4 and alpha5 integrin subunits in cerebral blood vessels of transgenic mice chronically producing the pro-inflammatory cytokines IL-6 or IFN-alpha in the central nervous system |
| Q37215932 | Increasing importance of Balamuthia mandrillaris |
| Q39628237 | Increasing of Blood-tumor Barrier Permeability through Paracellular Pathway by Low-frequency Ultrasound Irradiation In Vitro |
| Q36059965 | Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models |
| Q28538281 | Instruction of circulating endothelial progenitors in vitro towards specialized blood-brain barrier and arterial phenotypes |
| Q35107973 | Interaction of micron and nano-sized particles with cells of the dura mater |
| Q35708089 | Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings |
| Q45923746 | Interactions of the prion peptide (PrP 106-126) with brain capillary endothelial cells: coordinated cell killing and remodeling of intercellular junctions. |
| Q52562684 | Interfacing Graphene-Based Materials With Neural Cells. |
| Q38725361 | Into rather unexplored terrain-transcellular transport across the blood-brain barrier |
| Q46890566 | Kv1 and Kir2 potassium channels are expressed in rat brain endothelial cells |
| Q52654675 | Lactational exposure of phthalate causes long-term disruption in testicular architecture by altering tight junctional and apoptotic protein expression in Sertoli cells of first filial generation pubertal Wistar rats. |
| Q34229756 | Late stage infection in sleeping sickness |
| Q40742606 | Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood-retina barrier. |
| Q34041547 | Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling |
| Q36314837 | Limb Ischemic Perconditioning Attenuates Blood-Brain Barrier Disruption by Inhibiting Activity of MMP-9 and Occludin Degradation after Focal Cerebral Ischemia |
| Q38078421 | Liposomes for brain delivery |
| Q30362081 | Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound |
| Q37777780 | Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches |
| Q41845503 | Loss of Integrity: Impairment of the Blood-brain Barrier in Heavy Metal-associated Ischemic Stroke |
| Q57823139 | Loss of Regulator of G-Protein Signaling 5 Leads to Neurovascular Protection in Stroke |
| Q37739229 | Low-dose penicillin in early life induces long-term changes in murine gut microbiota, brain cytokines and behavior |
| Q35578905 | MPP1 as a Factor Regulating Phase Separation in Giant Plasma Membrane-Derived Vesicles |
| Q35751741 | Manganese neurotoxicity: a focus on the neonate |
| Q38366240 | Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain |
| Q47843849 | Mapping Extracellular pH of Gliomas in Presence of Superparamagnetic Nanoparticles: Towards Imaging the Distribution of Drug-Containing Nanoparticles and Their Curative Effect on the Tumor Microenvironment |
| Q33998763 | Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins |
| Q35920564 | Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage |
| Q42474751 | Matrix metalloproteinase-9 mediates post-hypoxic vascular pruning of cerebral blood vessels by degrading laminin and claudin-5. |
| Q39463653 | Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier |
| Q64448505 | Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain |
| Q52654285 | Melatonin treatment protects against acute spinal cord injury-induced disruption of blood spinal cord barrier in mice. |
| Q37682953 | Mesocestoides corti intracranial infection as a murine model for neurocysticercosis |
| Q37209324 | Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life |
| Q38117056 | Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research |
| Q37184157 | Microbial induction of vascular pathology in the CNS. |
| Q41670106 | Microdevice Platform for In Vitro Nervous System and Its Disease Model. |
| Q38199403 | Microfluidic approaches for epithelial cell layer culture and characterisation |
| Q36980988 | Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow. |
| Q50295671 | Modelling physiological and pathological conditions to study pericyte biology in brain function and dysfunction. |
| Q36220289 | Models and mechanisms for hippocampal dysfunction in obesity and diabetes |
| Q38774697 | Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids |
| Q38010642 | Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair |
| Q38139823 | Monocyte chemoattractant protein-1 and the blood-brain barrier |
| Q35849990 | Monocytes form a vascular barrier and participate in vessel repair after brain injury |
| Q35154529 | Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders |
| Q38824367 | Morphogens and blood-brain barrier function in health and disease |
| Q48714712 | Morphological approach to assess the involvement of astrocytes in prion propagation |
| Q46503083 | Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. |
| Q37776054 | Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms |
| Q37798870 | Nano to micro delivery systems: targeting angiogenesis in brain tumors |
| Q38156382 | Nano-enabled delivery systems across the blood-brain barrier |
| Q38334868 | Nanomaterials and neurodegeneration. |
| Q64064209 | Nanomaterials for Drug Delivery to the Central Nervous System |
| Q26747148 | Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases |
| Q38275050 | Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance |
| Q30672749 | Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier |
| Q38115775 | Neural circuit mechanisms of post-traumatic epilepsy |
| Q52689036 | Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions. |
| Q57811980 | Neuroinflammation, oxidative stress, and blood-brain barrier (BBB) disruption in acute Utah electrode array implants and the effect of deferoxamine as an iron chelator on acute foreign body response |
| Q26745615 | Neuroinvasion and Inflammation in Viral Central Nervous System Infections |
| Q33670796 | Neuron-glial interactions in blood-brain barrier formation. |
| Q35653077 | Neuronal connexin36 association with zonula occludens-1 protein (ZO-1) in mouse brain and interaction with the first PDZ domain of ZO-1. |
| Q36492361 | Neuroprotection in primary brain tumors: sense or nonsense? |
| Q36942721 | Neurovascular unit in chronic pain |
| Q85102460 | Neutrophils cross the BBB primarily on transcellular pathways: An in vitro study |
| Q30440266 | Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature |
| Q37083995 | Noninvasive molecular neuroimaging using reporter genes: part II, experimental, current, and future applications |
| Q37176938 | Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia |
| Q48524462 | OX26 modified hyperbranched polyglycerol-conjugated poly(lactic-co-glycolic acid) nanoparticles: synthesis, characterization and evaluation of its brain delivery ability |
| Q36248862 | Ontogeny of tight junction protein expression in the ovine cerebral cortex during development |
| Q64265564 | Oral Mucosal Epithelial Cells |
| Q35575520 | Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees |
| Q38836349 | Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin |
| Q37610820 | Past and recent BBB studies with particular emphasis on changes in ischemic brain edema: dedicated to the memory of Dr. Igor Klatzo |
| Q26777643 | Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products |
| Q37592281 | Pathogen translocation across the blood-brain barrier |
| Q58701395 | Pathogenesis of hepatic encephalopathy |
| Q38111646 | Pathogenesis of meningococcemia |
| Q26852773 | Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers |
| Q41988859 | Pcbs and tight junction expression |
| Q40306137 | Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria. |
| Q92421241 | Pericytes in Glioblastomas: Multifaceted Role Within Tumor Microenvironments and Potential for Therapeutic Interventions |
| Q38039410 | Perlecan and the blood-brain barrier: beneficial proteolysis? |
| Q39024369 | Permeability of the blood-tumor barrier is enhanced by combining vascular endothelial growth factor with papaverine |
| Q36166111 | Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. |
| Q28265568 | Pertussis toxin transiently affects barrier integrity, organelle organization and transmigration of monocytes in a human brain microvascular endothelial cell barrier model |
| Q36559702 | Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. |
| Q42215950 | Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier |
| Q46592570 | Polychlorinated biphenyls impair blood-brain barrier integrity via disruption of tight junction proteins in cerebrum, cerebellum and hippocampus of female Wistar rats: neuropotential role of quercetin |
| Q40302090 | Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells |
| Q37381816 | Progranulin deficiency promotes post-ischemic blood-brain barrier disruption |
| Q34043168 | Protection after stroke: cellular effectors of neurovascular unit integrity. |
| Q39069181 | Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability |
| Q37157311 | Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis |
| Q37812799 | Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics |
| Q38541950 | RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies |
| Q42514650 | Real-time acquisition of transendothelial electrical resistance in an all-human, in vitro, 3-dimensional, blood-brain barrier model exemplifies tight-junction integrity. |
| Q31154008 | Recent advances in blood-brain barrier disruption as a CNS delivery strategy |
| Q47378913 | Recent advances in nanomedicine and survivin targeting in brain cancers |
| Q34873529 | Recombinant human sonic hedgehog protein regulates the expression of ZO-1 and occludin by activating angiopoietin-1 in stroke damage |
| Q39906454 | Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin |
| Q48925891 | Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier |
| Q36986806 | Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit |
| Q42694289 | Retinal and Cortical Blood Flow Dynamics Following Systemic Blood-Neural Barrier Disruption |
| Q36091834 | Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. |
| Q45028397 | Reversible disruption of tight junction complexes in the rat blood-brain barrier, following transitory focal astrocyte loss |
| Q58551285 | Review Article: Capturing the physiological complexity of the brain's neuro-vascular unit |
| Q33488361 | Role of KCNMA1 gene in breast cancer invasion and metastasis to brain |
| Q48515470 | Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase |
| Q54584375 | Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB. |
| Q35127976 | Role of interendothelial adhesion molecules in the control of vascular functions |
| Q41830315 | Role of interleukin-1beta in early brain injury after subarachnoid hemorrhage in mice |
| Q39449749 | Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases. |
| Q37899111 | Role of the MAGUK protein family in synapse formation and function. |
| Q38862486 | Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier |
| Q92846319 | Seasonal adaptations of the hypothalamo-neurohypophyseal system of the dromedary camel |
| Q38697509 | Sepsis-Associated Encephalopathy: The Blood-Brain Barrier and the Sphingolipid Rheostat |
| Q96686012 | Sex dependent effects of post-natal penicillin on brain, behavior and immune regulation are prevented by concurrent probiotic treatment |
| Q28203769 | Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice |
| Q37124122 | Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo |
| Q50282885 | Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood-brain barrier in a focal cerebral ischemic insult. |
| Q26995931 | Steps to translate preconditioning from basic research to the clinic |
| Q38182668 | Strategies for drug delivery to the central nervous system by systemic route |
| Q38730602 | Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier |
| Q30871112 | Studying the neurovascular unit: an improved blood-brain barrier model |
| Q91161153 | Sublamina-specific organization of the blood brain barrier in the mouse olfactory nerve layer |
| Q37161062 | Superoxide dismutase-loaded PLGA nanoparticles protect cultured human neurons under oxidative stress |
| Q36287281 | Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats |
| Q48223017 | Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture. |
| Q45876651 | Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems. |
| Q36449224 | TAT-GDNF in neurodegeneration and ischemic stroke. |
| Q27010580 | Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide |
| Q38598523 | Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. |
| Q37810007 | The Blood-Retinal Barrier: Structure and Functional Significance |
| Q36832869 | The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology? |
| Q42114054 | The Effects of Copper on Brain Microvascular Endothelial Cells and Claudin Via Apoptosis and Oxidative Stress |
| Q51732646 | The Endo-Lysosomal System of Brain Endothelial Cells Is Influenced by Astrocytes In Vitro. |
| Q58790366 | The Hippocampal Neuro-Glio-Vascular Network: Metabolic Vulnerability and Potential Neurogenic Regeneration in Disease |
| Q37603088 | The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. |
| Q86905010 | The blood-brain barrier |
| Q37385549 | The blood-brain barrier in neurodegenerative disease: a rhetorical perspective |
| Q38134725 | The blood-brain barrier: an engineering perspective. |
| Q38232202 | The blood-brain barrier: structure, function and therapeutic approaches to cross it. |
| Q28299076 | The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting |
| Q48196105 | The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment |
| Q37156631 | The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. |
| Q30450592 | The effects of a high-energy diet on hippocampal-dependent discrimination performance and blood-brain barrier integrity differ for diet-induced obese and diet-resistant rats |
| Q35413892 | The gut microbiota influences blood-brain barrier permeability in mice |
| Q34442604 | The impact of microglial activation on blood-brain barrier in brain diseases. |
| Q33648688 | The molecular and biophysical characterization of the human blood-nerve barrier: current concepts |
| Q33898503 | The role of shear stress in Blood-Brain Barrier endothelial physiology |
| Q39756110 | The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth |
| Q47403727 | The temporospatial expression of peripheral myelin protein 22 at the developing blood-nerve and blood-brain barriers |
| Q47724056 | Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease |
| Q30407443 | Therapeutic strategies to improve drug delivery across the blood-brain barrier |
| Q40512823 | Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. |
| Q38193357 | Tight junction dynamics: the role of junctional adhesion molecules (JAMs). |
| Q36812411 | Tight junction modulation of the blood brain barrier: CNS delivery of small molecules |
| Q36410566 | Tight junction strand formation by claudin-10 isoforms and claudin-10a/-10b chimeras. |
| Q37139446 | Tight junctions and the modulation of barrier function in disease |
| Q36400271 | Tight junctions: molecular architecture and function |
| Q39006683 | Time-resolved cellular effects induced by TcdA from Clostridium difficile |
| Q90529676 | Tissue Plasminogen Activator Causes Brain Microvascular Endothelial Cell Injury After Oxygen Glucose Deprivation by Inhibiting Sonic Hedgehog Signaling |
| Q44992417 | Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells. |
| Q36991072 | Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. |
| Q35751067 | Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. |
| Q28484634 | Transcriptional control of the multi-drug transporter ABCB1 by transcription factor Sp3 in different human tissues |
| Q37394773 | Transcriptional profiling of human cavernosal endothelial cells reveals distinctive cell adhesion phenotype and role for claudin 11 in vascular barrier function |
| Q34328845 | Transcriptome analysis of the Octopus vulgaris central nervous system |
| Q48752367 | Treatment with Isorhamnetin Protects the Brain Against Ischemic Injury in Mice |
| Q35622297 | Triggers and mediators of hemorrhagic transformation in cerebral ischemia |
| Q92405024 | Tumor microenvironment differences between primary tumor and brain metastases |
| Q33217988 | Tumoral micro-blood vessels and vascular microenvironment in human astrocytic tumors. A transmission electron microscopy study |
| Q44701197 | Use of albumin quotient and IgG index to differentiate blood- vs brain-derived proteins in the cerebrospinal fluid of cats with feline infectious peritonitis |
| Q47357133 | VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy |
| Q88905954 | Vascular endothelial growth factor aggravates cerebral ischemia and reperfusion-induced blood-brain-barrier disruption through regulating LOC102640519/HOXC13/ZO-1 signaling |
| Q35947353 | Viable "Haemophilus somnus" induces myosin light-chain kinase-dependent decrease in brain endothelial cell monolayer resistance |
| Q92309537 | Weisheng-Tang Ameliorates Acute Ischemic Brain Damage in Mice by Maintaining Blood-Brain Barrier Integrity |
| Q22251221 | Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity |
| Q38958450 | miR-34c regulates the permeability of blood-tumor barrier via MAZ-mediated expression changes of ZO-1, occludin, and claudin-5. |
| Q33819951 | miR-Let7A Controls the Cell Death and Tight Junction Density of Brain Endothelial Cells under High Glucose Condition. |
| Q44819014 | t-PA reduces ischemic impairment of blood-brain barrier by strengthening endothelium junction |
| Q41430066 | β2-Adrenergic Receptor-Mediated HIF-1α Upregulation Mediates Blood Brain Barrier Damage in Acute Cerebral Ischemia |